IL5RA and Alzheimer disease: Nevertheless, further studies on a larger cohort of patients should be conducted to clarify whether IL-5R may be a potential biomarker of CSU and AD, prognostic tool prior to exacerbations, or new effective targeted therapies in the era of personalized medicine.